Healthcare Sector Stocks
The Healthcare sector has a total of 1053 stocks, with a combined market cap of $9.07 trillion, total revenue of $4.64 trillion and a weighted average PE ratio of 48.40.
Market Cap
9.07T
Revenue
4.64T
Profits
187.44B
PE Ratio
48.40
Profit Margin
4.04%
Dividend Yield
0.39%
1054 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | 3.77% | 1,838,434 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 619.46B | 0.83% | 929,094 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 439.16B | 1.94% | 777,955 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 371.87B | 0.47% | 1,311,015 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 322.41B | 1.98% | 1,295,584 | 66.57B |
| 6 | NVS | Novartis AG | 292.53B | 1.08% | 300,588 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 244.84B | 4.56% | 3,086,787 | 61.37B |
| 8 | AMGN | Amgen Inc. | 222.75B | 5.57% | 1,619,942 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 212.64B | 1.83% | 187,436 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 209.62B | 2.76% | 7,668,105 | 50.34B |
| 11 | ABT | Abbott Laboratories | 181.07B | -0.78% | 886,786 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 163.89B | -2.36% | 3,464,290 | 30.46B |
| 13 | PFE | Pfizer Inc. | 145.06B | 0.16% | 7,274,186 | 63.70B |
| 14 | DHR | Danaher Corporation | 139.68B | 2.01% | 504,691 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 131.60B | 1.16% | 664,427 | 11.03B |
| 16 | BMY | Bristol-Myers Squibb Company | 130.06B | -3.37% | 4,079,690 | 49.19B |
| 17 | SYK | Stryker Corporation | 129.37B | 0.39% | 275,143 | 25.84B |
| 18 | CVS | CVS Health Corporation | 124.49B | -6.56% | 6,835,744 | 412.85B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 123.49B | 1.78% | 196,897 | 12.59B |
| 20 | MDT | Medtronic plc | 109.93B | -0.37% | 626,290 | 36.36B |
| 21 | GSK | GSK plc | 103.15B | 0.74% | 640,232 | 44.05B |
| 22 | SNY | Sanofi | 102.64B | 0.81% | 465,586 | 55.89B |
| 23 | MCK | McKesson Corporation | 99.65B | 2.49% | 153,625 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 88.07B | 1.51% | 165,982 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 83.08B | 1.35% | 177,120 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 77.37B | 1.86% | 89,585 | 15.53B |
| 27 | CI | The Cigna Group | 71.39B | -1.42% | 509,112 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 69.51B | -2.30% | 2,456,445 | 21.00B |
| 29 | COR | Cencora, Inc. | 62.13B | 4.25% | 403,686 | 332.77B |
| 30 | CAH | Cardinal Health, Inc. | 55.55B | 1.56% | 257,699 | 250.74B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 53.40B | 0.60% | 913,533 | 28.42B |
| 32 | ARGX | argenx SE | 52.43B | 2.91% | 82,897 | 5.32B |
| 33 | EW | Edwards Lifesciences Corporation | 52.01B | 0.70% | 679,396 | 6.51B |
| 34 | MDLN | Medline Inc. | 47.49B | -14.01% | 5,193,256 | 29.94B |
| 35 | BDX | Becton, Dickinson and Company | 46.83B | -0.10% | 239,703 | 22.23B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 46.69B | 0.65% | 109,066 | 4.55B |
| 37 | HUM | Humana Inc. | 43.55B | 0.14% | 236,105 | 145.68B |
| 38 | HLN | Haleon plc | 42.37B | 1.07% | 1,947,146 | 14.80B |
| 39 | RVMD | Revolution Medicines, Inc. | 41.59B | 1.13% | 276,166 | - |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 40.60B | 1.19% | 974,629 | 17.32B |
| 41 | NTRA | Natera, Inc. | 39.85B | 1.10% | 94,178 | 2.50B |
| 42 | A | Agilent Technologies, Inc. | 39.78B | 1.19% | 104,660 | 7.23B |
| 43 | WAT | Waters Corporation | 38.86B | -0.07% | 147,345 | 4.64B |
| 44 | IQV | IQVIA Holdings Inc. | 38.72B | 3.08% | 272,004 | 16.98B |
| 45 | ONC | BeOne Medicines AG | 36.78B | 2.43% | 120,760 | 6.13B |
| 46 | VEEV | Veeva Systems Inc. | 34.48B | 0.19% | 223,334 | 3.32B |
| 47 | ALC | Alcon Inc. | 34.47B | -0.31% | 195,169 | 10.63B |
| 48 | RPRX | Royalty Pharma plc | 33.49B | 1.19% | 545,102 | 2.54B |
| 49 | CNC | Centene Corporation | 32.86B | 3.82% | 1,248,786 | 180.30B |
| 50 | RMD | ResMed Inc. | 32.24B | 0.17% | 224,062 | 5.54B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 31.97B | 0.74% | 388,528 | 21.27B |
| 52 | DXCM | DexCom, Inc. | 31.68B | -3.43% | 1,467,185 | 4.97B |
| 53 | ZTS | Zoetis Inc. | 31.27B | -1.89% | 1,809,378 | 9.53B |
| 54 | BIIB | Biogen Inc. | 31.17B | 1.22% | 79,806 | 10.03B |
| 55 | ILMN | Illumina, Inc. | 30.48B | -0.58% | 250,147 | 4.49B |
| 56 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.30B | 3.41% | 390,627 | 4.80B |
| 57 | MTD | Mettler-Toledo International Inc. | 28.83B | 0.14% | 13,601 | 4.13B |
| 58 | DGX | Quest Diagnostics Incorporated | 26.01B | 0.82% | 78,702 | 11.56B |
| 59 | PHG | Koninklijke Philips N.V. | 25.76B | 0.11% | 128,104 | 20.18B |
| 60 | LH | Labcorp Holdings Inc. | 25.40B | 0.51% | 48,942 | 14.35B |
| 61 | ROIV | Roivant Sciences Ltd. | 25.23B | 1.40% | 678,421 | 8.26M |
| 62 | WST | West Pharmaceutical Services, Inc. | 24.94B | 1.61% | 57,244 | 3.33B |
| 63 | INCY | Incyte Corporation | 24.72B | 1.12% | 335,943 | 5.82B |
| 64 | MRNA | Moderna, Inc. | 23.55B | 3.51% | 1,198,175 | 2.23B |
| 65 | BNTX | BioNTech SE | 23.45B | 1.50% | 264,113 | 3.23B |
| 66 | STE | STERIS plc | 22.53B | -0.73% | 107,417 | 5.94B |
| 67 | UTHR | United Therapeutics Corporation | 22.06B | 0.21% | 184,374 | 3.15B |
| 68 | GH | Guardant Health, Inc. | 21.86B | 1.96% | 197,825 | 1.18B |
| 69 | INSM | Insmed Incorporated | 21.66B | 1.21% | 668,083 | 819.56M |
| 70 | VTRS | Viatris Inc. | 20.73B | 0.59% | 792,473 | 14.56B |
| 71 | THC | Tenet Healthcare Corporation | 20.46B | 0.29% | 106,796 | 21.81B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 19.17B | 3.43% | 970,518 | 8.51B |
| 73 | GMAB | Genmab A/S | 17.76B | 1.38% | 300,511 | 3.90B |
| 74 | JAZZ | Jazz Pharmaceuticals plc | 17.03B | 0.25% | 75,481 | 4.60B |
| 75 | NBIX | Neurocrine Biosciences, Inc. | 16.79B | -0.51% | 190,721 | 3.37B |
| 76 | MEDP | Medpace Holdings, Inc. | 16.31B | 1.62% | 15,593 | 2.78B |
| 77 | ASND | Ascendis Pharma A/S | 16.25B | 0.76% | 63,509 | 998.25M |
| 78 | BBIO | BridgeBio Pharma, Inc. | 16.14B | 0.58% | 241,108 | 579.96M |
| 79 | SOLV | Solventum Corporation | 15.03B | -1.31% | 70,223 | 8.26B |
| 80 | COO | The Cooper Companies, Inc. | 14.63B | 0.42% | 167,373 | 4.23B |
| 81 | BAX | Baxter International Inc. | 14.21B | -3.03% | 1,642,612 | 11.47B |
| 82 | EXEL | Exelixis, Inc. | 14.18B | 0.77% | 227,184 | 2.38B |
| 83 | ELAN | Elanco Animal Health Incorporated | 13.79B | 7.85% | 3,428,461 | 5.02B |
| 84 | BTSG | BrightSpring Health Services, Inc. | 13.42B | 1.99% | 460,185 | 14.37B |
| 85 | PEN | Penumbra, Inc. | 12.73B | -0.30% | 27,210 | 1.50B |
| 86 | ICLR | ICON Public Limited Company | 12.73B | 5.19% | 136,828 | 8.29B |
| 87 | SNN | Smith & Nephew plc | 12.69B | -1.18% | 378,690 | 6.30B |
| 88 | FMS | Fresenius Medical Care AG | 12.65B | -0.96% | 421,998 | 22.20B |
| 89 | CRL | Charles River Laboratories International, Inc. | 12.63B | 12.02% | 404,310 | 4.00B |
| 90 | RVTY | Revvity, Inc. | 12.54B | 0.92% | 224,955 | 2.91B |
| 91 | ALGN | Align Technology, Inc. | 12.50B | 0.75% | 87,976 | 4.14B |
| 92 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.44B | -1.44% | 259,347 | 669.50M |
| 93 | DVA | DaVita Inc. | 12.09B | -17.42% | 1,485,079 | 14.01B |
| 94 | CORT | Corcept Therapeutics Incorporated | 12.06B | 1.59% | 104,867 | 830.81M |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.76B | 0.27% | 32,986 | 1.28B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 11.74B | 0.03% | 110,643 | 3.24B |
| 97 | TECH | Bio-Techne Corporation | 11.23B | -0.01% | 442,847 | 1.21B |
| 98 | AXSM | Axsome Therapeutics, Inc. | 11.05B | 1.20% | 65,822 | 708.24M |
| 99 | GMED | Globus Medical, Inc. | 10.98B | -0.74% | 144,629 | 3.10B |
| 100 | EHC | Encompass Health Corporation | 10.97B | 0.05% | 87,092 | 6.07B |
| 101 | SMMT | Summit Therapeutics Inc. | 10.90B | -0.73% | 294,194 | - |
| 102 | ABVX | ABIVAX Société Anonyme | 10.79B | 2.86% | 295,272 | 5.67M |
| 103 | CYTK | Cytokinetics, Incorporated | 10.66B | -0.15% | 160,771 | 105.82M |
| 104 | RDY | Dr. Reddy's Laboratories Limited | 10.28B | 0.74% | 246,223 | 3.50B |
| 105 | UHS | Universal Health Services, Inc. | 10.26B | 0.96% | 104,460 | 18.11B |
| 106 | ENSG | The Ensign Group, Inc. | 10.13B | -0.47% | 23,516 | 5.49B |
| 107 | APGE | Apogee Therapeutics, Inc. | 10.07B | -0.01% | 579,571 | - |
| 108 | HALO | Halozyme Therapeutics, Inc. | 10.00B | 1.30% | 104,062 | 1.51B |
| 109 | GKOS | Glaukos Corporation | 9.99B | -0.66% | 79,459 | 612.84M |
| 110 | MOH | Molina Healthcare, Inc. | 9.95B | -0.20% | 94,325 | 42.47B |
| 111 | HSIC | Henry Schein, Inc. | 9.89B | -0.86% | 192,506 | 13.60B |
| 112 | PODD | Insulet Corporation | 9.52B | -17.65% | 2,221,845 | 3.05B |
| 113 | KRYS | Krystal Biotech, Inc. | 9.44B | -1.75% | 51,346 | 440.48M |
| 114 | OSCR | Oscar Health, Inc. | 9.31B | 1.74% | 1,045,419 | 13.30B |
| 115 | BIO | Bio-Rad Laboratories, Inc. | 9.30B | 4.42% | 103,723 | 2.59B |
| 116 | SYRE | Spyre Therapeutics, Inc. | 9.28B | 0.61% | 241,143 | - |
| 117 | AVTR | Avantor, Inc. | 9.20B | -0.62% | 873,151 | 6.56B |
| 118 | IONS | Ionis Pharmaceuticals, Inc. | 9.11B | -0.49% | 116,735 | 874.09M |
| 119 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.90B | 0.06% | 472,891 | 42.16M |
| 120 | PRAX | Praxis Precision Medicines, Inc. | 8.86B | 2.48% | 20,777 | 7.46M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 8.86B | 1.42% | 33,288 | 74.06M |
| 122 | KYMR | Kymera Therapeutics, Inc. | 8.78B | 2.26% | 68,694 | 105.00M |
| 123 | QGEN | Qiagen N.V. | 8.73B | -0.26% | 183,699 | 2.10B |
| 124 | HQY | HealthEquity, Inc. | 8.70B | -0.85% | 72,578 | 1.34B |
| 125 | ATR | AptarGroup, Inc. | 8.64B | -0.23% | 25,207 | 3.93B |
| 126 | TEM | Tempus AI, Inc. | 8.63B | 1.64% | 781,143 | 1.43B |
| 127 | RGEN | Repligen Corporation | 8.61B | 1.91% | 91,099 | 785.10M |
| 128 | ALKS | Alkermes plc | 8.49B | 1.83% | 124,400 | 1.67B |
| 129 | IMVT | Immunovant, Inc. | 8.19B | 0.86% | 123,472 | - |
| 130 | LQDA | Liquidia Corporation | 8.10B | 3.08% | 134,252 | 288.07M |
| 131 | PCVX | Vaxcyte, Inc. | 8.09B | 2.51% | 136,563 | - |
| 132 | BRKR | Bruker Corporation | 7.89B | 3.06% | 847,878 | 3.50B |
| 133 | IBRX | ImmunityBio, Inc. | 7.70B | 5.76% | 2,501,166 | 165.79M |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.59B | 4.23% | 176,760 | 239.92M |
| 135 | HIMS | Hims & Hers Health, Inc. | 7.41B | -0.48% | 2,167,619 | 2.37B |
| 136 | COGT | Cogent Biosciences, Inc. | 7.20B | -1.66% | 302,581 | - |
| 137 | GRFS | Grifols, S.A. | 7.03B | -1.86% | 70,541 | 8.48B |
| 138 | CHE | Chemed Corporation | 7.01B | -0.14% | 41,708 | 2.60B |
| 139 | TWST | Twist Bioscience Corporation | 7.01B | 12.37% | 1,081,613 | 431.80M |
| 140 | TGTX | TG Therapeutics, Inc. | 7.00B | 1.41% | 348,681 | 799.54M |
| 141 | HNGE | Hinge Health, Inc. | 6.86B | 11.57% | 1,328,013 | 720.06M |
| 142 | PACS | PACS Group, Inc. | 6.81B | -4.02% | 507,719 | 5.55B |
| 143 | BLLN | BillionToOne, Inc. | 6.77B | 3.43% | 119,745 | 354.54M |
| 144 | LNTH | Lantheus Holdings, Inc. | 6.59B | 0.08% | 238,851 | 1.55B |
| 145 | ERAS | Erasca, Inc. | 6.50B | 1.88% | 405,179 | - |
| 146 | MIRM | Mirum Pharmaceuticals, Inc. | 6.45B | 1.43% | 87,438 | 569.61M |
| 147 | CGON | CG Oncology, Inc. | 6.43B | 2.04% | 101,919 | 5.07M |
| 148 | XENE | Xenon Pharmaceuticals Inc. | 6.33B | 2.31% | 85,515 | 7.50M |
| 149 | BLTE | Belite Bio, Inc | 6.28B | 1.49% | 31,761 | - |
| 150 | TFX | Teleflex Incorporated | 6.24B | 0.63% | 94,662 | 2.13B |
| 151 | TXG | 10x Genomics, Inc. | 6.17B | 1.61% | 225,065 | 638.78M |
| 152 | TVTX | Travere Therapeutics, Inc. | 6.11B | 17.28% | 1,676,216 | 591.33M |
| 153 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.06B | 2.25% | 52,572 | 840.85M |
| 154 | LGND | Ligand Pharmaceuticals Incorporated | 6.03B | 1.24% | 20,163 | 274.48M |
| 155 | AMRX | Amneal Pharmaceuticals, Inc. | 6.03B | 2.22% | 151,236 | 3.12B |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 6.02B | -0.23% | 151,588 | 1.90M |
| 157 | BLCO | Bausch + Lomb Corporation | 5.96B | 0.03% | 20,723 | 5.32B |
| 158 | ORKA | Oruka Therapeutics, Inc. | 5.91B | -0.20% | 78,933 | - |
| 159 | SRRK | Scholar Rock Holding Corporation | 5.87B | 2.48% | 60,428 | - |
| 160 | PTCT | PTC Therapeutics, Inc. | 5.82B | 1.00% | 132,410 | 1.01B |
| 161 | DFTX | Definium Therapeutics, Inc. | 5.73B | 1.98% | 153,812 | - |
| 162 | STVN | Stevanato Group S.p.A. | 5.51B | 2.69% | 39,643 | 1.40B |
| 163 | RDNT | RadNet, Inc. | 5.33B | -2.12% | 63,018 | 2.14B |
| 164 | MMED | MiniMed Group, Inc. | 5.29B | -0.90% | 94,135 | 3.10B |
| 165 | CRSP | CRISPR Therapeutics AG | 5.18B | -0.86% | 242,824 | 13.39M |
| 166 | SHC | Sotera Health Company | 5.18B | 0.28% | 191,237 | 1.19B |
| 167 | MMSI | Merit Medical Systems, Inc. | 5.13B | 0.06% | 136,069 | 1.58B |
| 168 | DYN | Dyne Therapeutics, Inc. | 5.01B | 3.35% | 567,479 | - |
| 169 | ACAD | ACADIA Pharmaceuticals Inc. | 4.93B | 6.11% | 1,616,743 | 1.14B |
| 170 | EWTX | Edgewise Therapeutics, Inc. | 4.84B | 0.68% | 241,184 | - |
| 171 | PBLS | Parabilis Medicines, Inc. | 4.66B | 1.92% | 29,359 | - |
| 172 | MANE | Veradermics, Incorporated | 4.65B | 3.68% | 151,194 | - |
| 173 | CAI | Caris Life Sciences, Inc. | 4.61B | 1.37% | 730,345 | 907.29M |
| 174 | INDV | Indivior Pharmaceuticals, Inc. | 4.58B | 6.33% | 762,698 | 1.33B |
| 175 | CELC | Celcuity Inc. | 4.58B | 1.47% | 119,128 | - |
| 176 | NVST | Envista Holdings Corporation | 4.57B | 0.48% | 336,711 | 2.81B |
| 177 | WAY | Waystar Holding Corp. | 4.50B | -1.26% | 221,248 | 1.21B |
| 178 | RLAY | Relay Therapeutics, Inc. | 4.30B | 1.05% | 186,845 | 10.68M |
| 179 | LIVN | LivaNova PLC | 4.30B | -8.19% | 389,546 | 1.47B |
| 180 | TNGX | Tango Therapeutics, Inc. | 4.25B | 0.10% | 540,631 | 56.99M |
| 181 | ITGR | Integer Holdings Corporation | 4.24B | -0.07% | 312,415 | 1.84B |
| 182 | ICUI | ICU Medical, Inc. | 4.24B | -1.32% | 20,317 | 2.16B |
| 183 | IRTC | iRhythm Holdings, Inc. | 4.16B | -0.43% | 90,654 | 787.85M |
| 184 | ELVN | Enliven Therapeutics, Inc. | 4.16B | -2.59% | 204,247 | - |
| 185 | LFST | LifeStance Health Group, Inc. | 4.06B | 2.00% | 270,764 | 1.49B |
| 186 | CON | Concentra Group Holdings Parent, Inc. | 4.01B | 0.80% | 37,470 | 2.23B |
| 187 | ADPT | Adaptive Biotechnologies Corporation | 3.96B | 1.43% | 275,278 | 308.08M |
| 188 | VKTX | Viking Therapeutics, Inc. | 3.94B | 2.64% | 286,322 | - |
| 189 | DOCS | Doximity, Inc. | 3.91B | -0.73% | 173,993 | 644.86M |
| 190 | HAE | Haemonetics Corporation | 3.89B | 0.17% | 95,896 | 1.33B |
| 191 | DNLI | Denali Therapeutics Inc. | 3.86B | 0.62% | 180,140 | - |
| 192 | VCYT | Veracyte, Inc. | 3.84B | 2.87% | 123,259 | 561.90M |
| 193 | LEGN | Legend Biotech Corporation | 3.76B | 1.67% | 283,413 | 1.14B |
| 194 | WRBY | Warby Parker Inc. | 3.74B | 1.75% | 615,850 | 890.57M |
| 195 | RCUS | Arcus Biosciences, Inc. | 3.68B | 1.63% | 68,954 | 236.00M |
| 196 | GPCR | Structure Therapeutics Inc. | 3.59B | 1.73% | 97,716 | - |
| 197 | OGN | Organon & Co. | 3.57B | 0.15% | 833,739 | 6.13B |
| 198 | OPCH | Option Care Health, Inc. | 3.52B | -0.84% | 189,551 | 5.69B |
| 199 | TLX | Telix Pharmaceuticals Limited | 3.52B | 1.40% | 7,541 | 803.79M |
| 200 | ALMS | Alumis Inc. | 3.50B | 1.18% | 116,324 | 8.40M |
| 201 | IDYA | IDEAYA Biosciences, Inc. | 3.47B | 1.05% | 58,835 | 234.13M |
| 202 | BKD | Brookdale Senior Living Inc. | 3.44B | 1.30% | 273,041 | 3.00B |
| 203 | MBX | MBX Biosciences, Inc. | 3.38B | 0.58% | 77,402 | - |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.35B | 2.90% | 171,008 | 415.62M |
| 205 | NHC | National HealthCare Corporation | 3.35B | 2.88% | 28,243 | 1.53B |
| 206 | GRAL | GRAIL, Inc. | 3.18B | 1.87% | 41,180 | 156.12M |
| 207 | NAMS | NewAmsterdam Pharma Company N.V. | 3.16B | -1.92% | 373,613 | 22.57M |
| 208 | CLDX | Celldex Therapeutics, Inc. | 3.12B | 1.64% | 37,948 | 865.00K |
| 209 | QURE | uniQure N.V. | 3.07B | 1.40% | 85,739 | 18.67M |
| 210 | RGC | Regencell Bioscience Holdings Limited | 3.05B | 1.65% | 58,928 | - |
| 211 | ACHC | Acadia Healthcare Company, Inc. | 3.04B | 2.94% | 173,489 | 3.37B |
| 212 | IRON | Disc Medicine, Inc. | 3.03B | 1.30% | 29,637 | - |
| 213 | PRVA | Privia Health Group, Inc. | 3.01B | 0.42% | 58,614 | 2.25B |
| 214 | IMNM | Immunome, Inc. | 2.87B | 1.28% | 119,265 | 4.02M |
| 215 | ALHC | Alignment Healthcare, Inc. | 2.85B | 1.48% | 859,035 | 4.58B |
| 216 | ESTA | Establishment Labs Holdings Inc. | 2.83B | 1.69% | 111,431 | 229.58M |
| 217 | XRAY | DENTSPLY SIRONA Inc. | 2.80B | -1.89% | 527,707 | 3.68B |
| 218 | BEAM | Beam Therapeutics Inc. | 2.79B | -1.20% | 362,771 | 156.04M |
| 219 | KOD | Kodiak Sciences Inc. | 2.73B | 1.77% | 70,095 | - |
| 220 | SUPN | Supernus Pharmaceuticals, Inc. | 2.72B | 8.21% | 329,695 | 830.44M |
| 221 | TRVI | Trevi Therapeutics, Inc. | 2.68B | 0.64% | 187,051 | - |
| 222 | TARS | Tarsus Pharmaceuticals, Inc. | 2.66B | 1.13% | 39,386 | 535.08M |
| 223 | ATAI | AtaiBeckley Inc. | 2.65B | -0.07% | 2,276,335 | 3.49M |
| 224 | NRIX | Nurix Therapeutics, Inc. | 2.62B | 2.35% | 155,934 | 36.77M |
| 225 | PLSE | Pulse Biosciences, Inc. | 2.60B | -1.60% | 17,925 | 751.00K |
| 226 | GRDN | Guardian Pharmacy Services, Inc. | 2.58B | 0.43% | 24,888 | 1.46B |
| 227 | NEOG | Neogen Corporation | 2.56B | -0.68% | 409,660 | 870.40M |
| 228 | UFPT | UFP Technologies, Inc. | 2.53B | -2.36% | 60,902 | 631.64M |
| 229 | TMDX | TransMedics Group, Inc. | 2.52B | -9.62% | 1,153,014 | 668.47M |
| 230 | PBH | Prestige Consumer Healthcare Inc. | 2.48B | 0.77% | 75,451 | 1.09B |
| 231 | PGNY | Progyny, Inc. | 2.48B | 0.44% | 69,480 | 1.29B |
| 232 | NKTR | Nektar Therapeutics | 2.48B | 0.69% | 104,700 | 55.63M |
| 233 | RARE | Ultragenyx Pharmaceutical Inc. | 2.47B | -2.36% | 745,219 | 717.00M |
| 234 | PGEN | Precigen, Inc. | 2.46B | 5.67% | 5,610,384 | 85.72M |
| 235 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.43B | 0.14% | 112,508 | -665.00K |
| 236 | CDNA | CareDx, Inc. | 2.42B | -0.47% | 128,885 | 458.09M |
| 237 | AXGN | Axogen, Inc. | 2.42B | -2.11% | 72,541 | 251.17M |
| 238 | MLYS | Mineralys Therapeutics, Inc. | 2.39B | 2.15% | 45,070 | - |
| 239 | VCEL | Vericel Corporation | 2.38B | 0.17% | 41,316 | 306.30M |
| 240 | KLRA | Kailera Therapeutics, Inc. | 2.38B | 1.27% | 15,393 | - |
| 241 | HTFL | HeartFlow, Inc. | 2.35B | -0.11% | 46,125 | 191.42M |
| 242 | VRDN | Viridian Therapeutics, Inc. | 2.34B | 1.87% | 244,774 | 70.92M |
| 243 | BFLY | Butterfly Network, Inc. | 2.34B | -0.11% | 1,277,485 | 112.14M |
| 244 | BHC | Bausch Health Companies Inc. | 2.34B | -2.80% | 728,707 | 10.85B |
| 245 | PHVS | Pharvaris N.V. | 2.34B | -1.30% | 27,891 | - |
| 246 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.32B | 1.39% | 1,362,745 | 940.61M |
| 247 | SION | Sionna Therapeutics, Inc. | 2.30B | 2.20% | 97,244 | - |
| 248 | SLS | SELLAS Life Sciences Group, Inc. | 2.27B | -2.12% | 1,118,748 | - |
| 249 | COAG | Hemab Therapeutics Holdings, Inc. | 2.27B | 4.43% | 66,551 | - |
| 250 | NUVB | Nuvation Bio Inc. | 2.26B | 0.93% | 512,716 | 143.05M |
| 251 | CLOV | Clover Health Investments, Corp. | 2.26B | 0.47% | 512,468 | 2.21B |
| 252 | HRMY | Harmony Biosciences Holdings, Inc. | 2.25B | -0.37% | 145,507 | 959.90M |
| 253 | PVLA | Palvella Therapeutics, Inc. | 2.22B | 1.41% | 26,202 | - |
| 254 | VERA | Vera Therapeutics, Inc. | 2.21B | 2.80% | 377,908 | - |
| 255 | WGS | GeneDx Holdings Corp. | 2.15B | 1.58% | 151,028 | 454.43M |
| 256 | ADUS | Addus HomeCare Corporation | 2.11B | 1.71% | 60,283 | 1.48B |
| 257 | ADMA | ADMA Biologics, Inc. | 2.10B | 1.46% | 411,336 | 509.86M |
| 258 | STOK | Stoke Therapeutics, Inc. | 2.09B | 2.13% | 89,172 | 27.59M |
| 259 | NEO | NeoGenomics, Inc. | 2.08B | -0.43% | 203,094 | 766.30M |
| 260 | BHVN | Biohaven Ltd. | 2.08B | 0.29% | 106,206 | - |
| 261 | ZLAB | Zai Lab Limited | 2.08B | -0.08% | 30,294 | 453.28M |
| 262 | AVAH | Aveanna Healthcare Holdings Inc. | 2.06B | 0.85% | 181,476 | 2.52B |
| 263 | MD | Pediatrix Medical Group, Inc. | 2.05B | 4.57% | 170,784 | 1.95B |
| 264 | URGN | UroGen Pharma Ltd. | 2.04B | 4.98% | 360,204 | 188.73M |
| 265 | ZBIO | Zenas BioPharma, Inc. | 2.03B | 2.45% | 52,678 | 10.00M |
| 266 | HCM | HUTCHMED (China) Limited | 2.02B | -0.34% | 3,222 | 549.12M |
| 267 | SGRY | Surgery Partners, Inc. | 2.02B | -0.58% | 293,909 | 3.34B |
| 268 | TSHA | Taysha Gene Therapies, Inc. | 2.01B | 1.53% | 344,699 | 7.47M |
| 269 | RAPP | Rapport Therapeutics, Inc. | 2.01B | -0.52% | 29,157 | 20.00M |
| 270 | NBTX | Nanobiotix S.A. | 2.00B | 2.05% | 19,929 | 38.27M |
| 271 | IOVA | Iovance Biotherapeutics, Inc. | 2.00B | 2.75% | 1,792,369 | 285.61M |
| 272 | LMAT | LeMaitre Vascular, Inc. | 1.98B | -17.97% | 442,569 | 262.43M |
| 273 | GHRS | GH Research PLC | 1.98B | -0.82% | 19,300 | - |
| 274 | AUPH | Aurinia Pharmaceuticals Inc. | 1.96B | 1.88% | 177,610 | 298.30M |
| 275 | ATRC | AtriCure, Inc. | 1.95B | -1.79% | 58,235 | 569.62M |
| 276 | MESO | Mesoblast Limited | 1.95B | 2.16% | 16,583 | 65.38M |
| 277 | DMRA | Damora Therapeutics, Inc. | 1.93B | 4.35% | 132,179 | - |
| 278 | ALMR | Alamar Biosciences, Inc. | 1.91B | 1.59% | 8,632 | 87.16M |
| 279 | OCUL | Ocular Therapeutix, Inc. | 1.91B | 1.05% | 185,126 | 52.06M |
| 280 | AGIO | Agios Pharmaceuticals, Inc. | 1.89B | 0.35% | 82,562 | 98.34M |
| 281 | ABCL | AbCellera Biologics Inc. | 1.88B | 1.15% | 722,467 | 79.21M |
| 282 | KARD | Kardigan, Inc. | 1.88B | 2.51% | 13,140 | - |
| 283 | NVCR | NovoCure Limited | 1.87B | -1.17% | 114,991 | 699.19M |
| 284 | FBRX | Forte Biosciences, Inc. | 1.87B | 0.01% | 261,488 | - |
| 285 | GENB | Generate Biomedicines, Inc. | 1.87B | 2.03% | 61,919 | 30.30M |
| 286 | PRGO | Perrigo Company plc | 1.85B | 23.93% | 2,698,907 | 4.14B |
| 287 | FTRE | Fortrea Holdings Inc. | 1.84B | 7.45% | 519,784 | 2.68B |
| 288 | SNDA | Sonida Senior Living, Inc. | 1.82B | 1.23% | 30,084 | 367.34M |
| 289 | SEPN | Septerna, Inc. | 1.80B | 2.21% | 93,715 | 72.26M |
| 290 | INSP | Inspire Medical Systems, Inc. | 1.77B | -4.37% | 136,127 | 898.74M |
| 291 | ENOV | Enovis Corporation | 1.76B | -0.68% | 72,958 | 2.28B |
| 292 | LKFT | Lakefront Biotherapeutics NV | 1.76B | 0.85% | 45,549 | 1.20B |
| 293 | SRPT | Sarepta Therapeutics, Inc. | 1.75B | 1.28% | 264,035 | 2.18B |
| 294 | SNDX | Syndax Pharmaceuticals, Inc. | 1.74B | 3.14% | 952,045 | 252.25M |
| 295 | AGL | agilon health, inc. | 1.74B | 10.20% | 167,110 | 5.82B |
| 296 | BCAX | Bicara Therapeutics Inc. | 1.72B | 0.19% | 58,185 | - |
| 297 | ANIP | ANI Pharmaceuticals, Inc. | 1.71B | 1.96% | 14,920 | 923.71M |
| 298 | TYRA | Tyra Biosciences, Inc. | 1.70B | -11.91% | 556,553 | - |
| 299 | RXRX | Recursion Pharmaceuticals, Inc. | 1.70B | -3.32% | 7,105,255 | 54.86M |
| 300 | ZYME | Zymeworks Inc. | 1.70B | 4.04% | 55,256 | 81.26M |
| 301 | CMPS | COMPASS Pathways plc | 1.69B | 5.93% | 1,986,974 | - |
| 302 | IMCR | Immunocore Holdings plc | 1.68B | -0.45% | 57,471 | 412.81M |
| 303 | OMCL | Omnicell, Inc. | 1.68B | -0.75% | 31,033 | 1.25B |
| 304 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.68B | 0.93% | 116,000 | 204.73M |
| 305 | ANAB | AnaptysBio, Inc. | 1.65B | 1.03% | 31,080 | 232.39M |
| 306 | TRAX | First Tracks Biotherapeutics, Inc. | 1.65B | 2.70% | 106,989 | - |
| 307 | ASTH | Astrana Health, Inc. | 1.62B | 0.62% | 41,335 | 3.53B |
| 308 | BLFS | BioLife Solutions, Inc. | 1.61B | 1.29% | 182,821 | 101.66M |
| 309 | TRLV | Trulieve Cannabis Corp. | 1.61B | -5.96% | 234,053 | 1.17B |
| 310 | ARDT | Ardent Health, Inc. | 1.59B | 3.26% | 163,830 | 6.41B |
| 311 | MAZE | Maze Therapeutics, Inc. | 1.58B | 3.30% | 23,695 | 20.00M |
| 312 | HCSG | Healthcare Services Group, Inc. | 1.57B | -1.08% | 147,997 | 1.86B |
| 313 | NTLA | Intellia Therapeutics, Inc. | 1.57B | -0.80% | 604,832 | 66.09M |
| 314 | AAPG | Ascentage Pharma Group International | 1.57B | 1.32% | 1,321 | 82.08M |
| 315 | VIR | Vir Biotechnology, Inc. | 1.55B | 0.44% | 111,608 | 65.50M |
| 316 | INVA | Innoviva, Inc. | 1.54B | 0.14% | 43,360 | 420.69M |
| 317 | ATEC | Alphatec Holdings, Inc. | 1.54B | -3.43% | 786,362 | 787.08M |
| 318 | PAHC | Phibro Animal Health Corporation | 1.51B | 1.89% | 9,451 | 1.50B |
| 319 | HROW | Harrow, Inc. | 1.50B | 1.28% | 47,389 | 268.68M |
| 320 | XERS | Xeris Biopharma Holdings, Inc. | 1.50B | 1.10% | 225,871 | 314.85M |
| 321 | INNV | InnovAge Holding Corp. | 1.49B | 1.29% | 14,753 | 949.17M |
| 322 | XNCR | Xencor, Inc. | 1.48B | 0.50% | 152,432 | 97.36M |
| 323 | KMTS | Kestra Medical Technologies, Ltd. | 1.48B | -2.64% | 51,519 | 95.13M |
| 324 | CNMD | CONMED Corporation | 1.48B | -2.14% | 32,495 | 1.37B |
| 325 | MLTX | MoonLake Immunotherapeutics | 1.47B | -0.45% | 66,269 | - |
| 326 | AVBP | ArriVent BioPharma, Inc. | 1.46B | -0.38% | 31,024 | - |
| 327 | ABSI | Absci Corporation | 1.46B | 1.30% | 482,131 | 1.84M |
| 328 | PSNL | Personalis, Inc. | 1.43B | 1.26% | 383,651 | 69.67M |
| 329 | AVLN | Avalyn Pharma Inc. | 1.41B | 3.25% | 16,589 | - |
| 330 | ORIC | ORIC Pharmaceuticals, Inc. | 1.40B | 0.52% | 439,233 | - |
| 331 | SVRA | Savara Inc. | 1.40B | 1.85% | 167,095 | - |
| 332 | IART | Integra LifeSciences Holdings Corporation | 1.39B | -0.34% | 44,980 | 1.65B |
| 333 | GLUE | Monte Rosa Therapeutics, Inc. | 1.37B | 0.87% | 198,695 | 42.95M |
| 334 | ALVO | Alvotech | 1.36B | -0.65% | 172,782 | 562.04M |
| 335 | TNDM | Tandem Diabetes Care, Inc. | 1.34B | -3.22% | 366,227 | 1.03B |
| 336 | PNTG | The Pennant Group, Inc. | 1.33B | -0.78% | 104,117 | 1.02B |
| 337 | BVS | Bioventus Inc. | 1.31B | 16.77% | 821,666 | 581.85M |
| 338 | ETON | Eton Pharmaceuticals, Inc. | 1.31B | 4.06% | 55,591 | 86.93M |
| 339 | LBRX | LB Pharmaceuticals Inc | 1.31B | 1.20% | 41,493 | - |
| 340 | AZTA | Azenta, Inc. | 1.30B | -1.56% | 121,084 | 613.81M |
| 341 | JBIO | Jade Biosciences, Inc. | 1.30B | 2.30% | 58,151 | - |
| 342 | AMN | AMN Healthcare Services, Inc. | 1.30B | 0.51% | 63,378 | 3.42B |
| 343 | AKTS | Aktis Oncology, Inc. | 1.29B | 2.52% | 72,498 | 8.28M |
| 344 | IMTX | Immatics N.V. | 1.29B | 0.96% | 146,403 | 43.00M |
| 345 | FRNM | Freenome, Inc. | 1.28B | 3.57% | 529,085 | 34.24M |
| 346 | TDOC | Teladoc Health, Inc. | 1.27B | 4.32% | 1,338,672 | 2.49B |
| 347 | MNKD | MannKind Corporation | 1.27B | 0.51% | 804,602 | 360.78M |
| 348 | NVAX | Novavax, Inc. | 1.27B | 0.91% | 509,872 | 596.34M |
| 349 | AORT | Artivion, Inc. | 1.26B | -3.83% | 46,904 | 458.69M |
| 350 | VOR | Vor Biopharma Inc. | 1.24B | 2.92% | 103,792 | - |
| 351 | INBX | Inhibrx Biosciences, Inc. | 1.24B | 0.83% | 38,759 | 1.30M |
| 352 | ARDX | Ardelyx, Inc. | 1.23B | -0.90% | 423,661 | 427.68M |
| 353 | CERT | Certara, Inc. | 1.22B | 2.95% | 409,801 | 421.75M |
| 354 | AHG | Akso Health Group | 1.22B | - | 18 | 13.83M |
| 355 | OMDA | Omada Health, Inc. | 1.20B | 0.15% | 205,961 | 283.30M |
| 356 | QDEL | QuidelOrtho Corporation | 1.20B | 0.17% | 94,688 | 2.66B |
| 357 | SDGR | Schrödinger, Inc. | 1.20B | 2.62% | 271,403 | 254.91M |
| 358 | DRTS | Alpha Tau Medical Ltd. | 1.20B | 1.26% | 79,056 | - |
| 359 | CRVS | Corvus Pharmaceuticals, Inc. | 1.19B | 2.08% | 65,666 | - |
| 360 | IRMD | IRADIMED CORPORATION | 1.18B | -0.71% | 33,645 | 86.34M |
| 361 | COLL | Collegium Pharmaceutical, Inc. | 1.18B | 1.44% | 24,403 | 796.33M |
| 362 | WVE | Wave Life Sciences Ltd. | 1.17B | -0.83% | 209,498 | 65.37M |
| 363 | STAA | STAAR Surgical Company | 1.16B | -3.03% | 155,099 | 290.38M |
| 364 | MGTX | MeiraGTx Holdings plc | 1.16B | 2.12% | 61,815 | 79.76M |
| 365 | USPH | U.S. Physical Therapy, Inc. | 1.16B | 0.62% | 27,256 | 787.69M |
| 366 | SPTX | Seaport Therapeutics, Inc. | 1.16B | 0.86% | 6,841 | - |
| 367 | GDRX | GoodRx Holdings, Inc. | 1.12B | -1.20% | 160,098 | 787.89M |
| 368 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.11B | 0.40% | 489,624 | 69.64M |
| 369 | LMRI | Lumexa Imaging Holdings, Inc. | 1.09B | 0.26% | 21,115 | 1.03B |
| 370 | CGEM | Cullinan Therapeutics, Inc. | 1.09B | 1.14% | 58,726 | - |
| 371 | ANRO | Alto Neuroscience, Inc. | 1.09B | -0.85% | 42,877 | - |
| 372 | NUTX | Nutex Health Inc. | 1.09B | 0.11% | 18,338 | 879.95M |
| 373 | PRCT | PROCEPT BioRobotics Corporation | 1.08B | 3.61% | 1,652,952 | 337.34M |
| 374 | CRON | Cronos Group Inc. | 1.05B | -0.89% | 240,492 | 159.54M |
| 375 | EYPT | EyePoint, Inc. | 1.05B | 6.94% | 609,660 | 2.79M |
| 376 | OLMA | Olema Pharmaceuticals, Inc. | 1.03B | - | 93,597 | - |
| 377 | GERN | Geron Corporation | 1.03B | 19.40% | 12,093,083 | 204.56M |
| 378 | APMD | Apnimed, Inc. | 1.02B | -0.23% | 135,264 | 120.15M |
| 379 | REPL | Replimune Group, Inc. | 1.02B | 1.76% | 671,556 | - |
| 380 | SANA | Sana Biotechnology, Inc. | 1.02B | -0.29% | 328,927 | - |
| 381 | IVA | Inventiva S.A. | 1.02B | 2.66% | 167,055 | 7.94M |
| 382 | AVTX | Avalo Therapeutics, Inc. | 1.01B | 3.51% | 78,710 | 59.00K |
| 383 | PCRX | Pacira BioSciences, Inc. | 1.00B | -7.82% | 204,222 | 746.16M |
| 384 | OPK | OPKO Health, Inc. | 985.15M | 0.76% | 571,003 | 587.90M |
| 385 | JANX | Janux Therapeutics, Inc. | 984.90M | 1.19% | 39,918 | 13.73M |
| 386 | GMRS | GMR Solutions Inc. | 962.85M | -0.88% | 14,232 | 5.83B |
| 387 | ODTX | Odyssey Therapeutics, Inc. | 955.17M | -0.05% | 19,673 | 1.06M |
| 388 | OMER | Omeros Corporation | 947.39M | 1.16% | 194,104 | 9.89M |
| 389 | CSTL | Castle Biosciences, Inc. | 945.51M | -0.74% | 40,278 | 357.28M |
| 390 | ABUS | Arbutus Biopharma Corporation | 910.65M | 4.30% | 214,920 | 191.45M |
| 391 | AMPH | Amphastar Pharmaceuticals, Inc. | 889.80M | 1.41% | 21,580 | 720.53M |
| 392 | ANNX | Annexon, Inc. | 883.11M | 1.13% | 253,430 | - |
| 393 | AHCO | AdaptHealth Corp. | 875.92M | -1.94% | 1,339,608 | 3.36B |
| 394 | TBPH | Theravance Biopharma, Inc. | 875.38M | 0.06% | 62,911 | 109.78M |
| 395 | INMD | InMode Ltd. | 874.86M | -0.98% | 57,767 | 374.63M |
| 396 | TALK | Talkspace, Inc. | 871.90M | 1.07% | 114,606 | 238.37M |
| 397 | SLDB | Solid Biosciences Inc. | 866.36M | 2.09% | 135,799 | - |
| 398 | ACRS | Aclaris Therapeutics, Inc. | 850.55M | 1.84% | 967,850 | 8.37M |
| 399 | GLAS | Glass House Brands Inc. | 845.61M | -3.28% | 166,861 | 177.68M |
| 400 | HSTM | HealthStream, Inc. | 840.23M | -3.49% | 18,624 | 321.12M |
| 401 | DSGN | Design Therapeutics, Inc. | 837.97M | 1.44% | 29,240 | - |
| 402 | KURA | Kura Oncology, Inc. | 837.14M | -0.42% | 114,941 | 71.64M |
| 403 | SIBN | SI-BONE, Inc. | 806.71M | -1.36% | 41,616 | 213.60M |
| 404 | AVR | Anteris Technologies Global Corp. | 804.01M | -0.36% | 55,048 | 1.85M |
| 405 | SGP | SpyGlass Pharma, Inc. | 803.07M | -0.37% | 3,469 | - |
| 406 | DBVT | DBV Technologies S.A. | 788.61M | 3.57% | 105,123 | 5.04M |
| 407 | SSII | SS Innovations International, Inc. | 784.52M | 2.35% | 4,272 | 48.47M |
| 408 | CADL | Candel Therapeutics, Inc. | 783.99M | 1.81% | 139,595 | - |
| 409 | RIGL | Rigel Pharmaceuticals, Inc. | 780.97M | 9.07% | 146,867 | 276.79M |
| 410 | MNPR | Monopar Therapeutics Inc. | 779.74M | -1.74% | 51,631 | - |
| 411 | AURA | Aura Biosciences, Inc. | 778.71M | -1.26% | 38,478 | - |
| 412 | TENX | Tenax Therapeutics, Inc. | 770.44M | -2.68% | 261,868 | - |
| 413 | DRUG | Bright Minds Biosciences Inc. | 762.47M | 1.94% | 7,528 | - |
| 414 | OCS | Oculis Holding AG | 742.77M | 2.59% | 28,251 | 1.40M |
| 415 | PHAR | Pharming Group N.V. | 737.37M | 3.94% | 1,285 | 366.48M |
| 416 | AGMB | AgomAb Therapeutics NV | 731.58M | 0.85% | 2,361 | - |
| 417 | CTMX | CytomX Therapeutics, Inc. | 731.48M | 1.20% | 198,410 | 35.54M |
| 418 | IRWD | Ironwood Pharmaceuticals, Inc. | 726.77M | 2.44% | 325,030 | 361.51M |
| 419 | CLYM | Climb Bio, Inc. | 723.20M | 0.56% | 229,504 | - |
| 420 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 721.77M | 1.58% | 23,242 | - |
| 421 | EVO | Evotec SE | 705.43M | 2.05% | 151,819 | 859.03M |
| 422 | NGNE | Neurogene Inc. | 704.42M | 2.73% | 14,084 | 925.00K |
| 423 | CBIO | Crescent Biopharma, Inc. | 704.36M | 0.47% | 10,946 | 11.88M |
| 424 | PHR | Phreesia, Inc. | 700.33M | -0.96% | 40,136 | 495.59M |
| 425 | GYRE | Gyre Therapeutics, Inc. | 695.07M | 1.37% | 5,659 | 117.05M |
| 426 | CBLL | CeriBell, Inc. | 692.45M | -1.46% | 25,018 | 95.07M |
| 427 | PHAT | Phathom Pharmaceuticals, Inc. | 687.07M | 2.37% | 297,883 | 239.66M |
| 428 | ACHV | Achieve Life Sciences, Inc. | 685.76M | 3.25% | 119,237 | - |
| 429 | IMMX | Immix Biopharma, Inc. | 685.56M | 3.22% | 214,154 | - |
| 430 | TCMD | Tactile Systems Technology, Inc. | 676.69M | -0.46% | 18,764 | 343.52M |
| 431 | ALLO | Allogene Therapeutics, Inc. | 674.78M | 2.89% | 721,258 | 22.00K |
| 432 | RGNX | REGENXBIO Inc. | 660.84M | 3.98% | 193,544 | 87.82M |
| 433 | BBNX | Beta Bionics, Inc. | 650.55M | -0.75% | 84,505 | 119.01M |
| 434 | FTH | Faeth Therapeutics, Inc. | 638.02M | -2.94% | 26,345 | - |
| 435 | BWAY | BrainsWay Ltd. | 637.62M | -3.48% | 16,300 | 56.22M |
| 436 | NVCT | Nuvectis Pharma, Inc. | 636.82M | 0.50% | 33,899 | - |
| 437 | ZVRA | Zevra Therapeutics, Inc. | 623.66M | 0.29% | 91,228 | 122.29M |
| 438 | DNA | Ginkgo Bioworks Holdings, Inc. | 621.89M | 1.60% | 202,526 | 151.40M |
| 439 | MDXG | MiMedx Group, Inc. | 619.48M | -0.47% | 209,609 | 355.17M |
| 440 | ANGO | AngioDynamics, Inc. | 617.26M | -1.69% | 29,352 | 320.17M |
| 441 | TLRY | Tilray Brands, Inc. | 606.20M | -3.66% | 989,670 | 915.45M |
| 442 | HELP | Cybin Inc. | 604.96M | 5.17% | 451,505 | - |
| 443 | ALT | Altimmune, Inc. | 596.06M | -0.16% | 762,099 | 36.00K |
| 444 | STTK | Shattuck Labs, Inc. | 595.81M | -1.89% | 102,657 | 1.00M |
| 445 | MPLT | MapLight Therapeutics, Inc. | 594.48M | 1.31% | 134,966 | - |
| 446 | CTNM | Contineum Therapeutics, Inc. | 591.03M | -1.19% | 10,939 | - |
| 447 | CRMD | CorMedix Inc. | 587.60M | -0.40% | 72,841 | 400.05M |
| 448 | RLMD | Relmada Therapeutics, Inc. | 575.85M | 0.37% | 65,822 | - |
| 449 | KIDS | OrthoPediatrics Corp. | 562.18M | 3.11% | 65,202 | 252.72M |
| 450 | TECX | Tectonic Therapeutic, Inc. | 556.64M | 1.13% | 25,406 | - |
| 451 | SOPH | SOPHiA GENETICS SA | 552.87M | -3.65% | 205,709 | 86.17M |
| 452 | CTKB | Cytek Biosciences, Inc. | 552.73M | - | 72,851 | 204.17M |
| 453 | ZURA | Zura Bio Limited | 551.94M | 2.11% | 316,264 | - |
| 454 | FDMT | 4D Molecular Therapeutics, Inc. | 550.99M | 2.73% | 100,777 | 88.24M |
| 455 | WEAV | Weave Communications, Inc. | 547.81M | 0.22% | 71,399 | 248.72M |
| 456 | PRME | Prime Medicine, Inc. | 545.46M | 1.34% | 658,211 | 4.03M |
| 457 | ARVN | Arvinas, Inc. | 539.38M | -8.22% | 536,875 | 316.70M |
| 458 | EIKN | Eikon Therapeutics, Inc. | 539.22M | 4.18% | 34,257 | - |
| 459 | SPRY | ARS Pharmaceuticals, Inc. | 529.29M | 0.19% | 444,769 | 98.99M |
| 460 | ANL | Adlai Nortye Ltd. | 525.20M | 1.00% | 7,822 | 5.00M |
| 461 | STLN | Starling Oncology, Inc. | 523.91M | 1.35% | 136,803 | 545.76M |
| 462 | ARTV | Artiva Biotherapeutics, Inc. | 520.87M | -3.16% | 86,768 | 251.00K |
| 463 | SGMT | Sagimet Biosciences Inc. | 520.57M | 5.51% | 237,559 | - |
| 464 | SLN | Silence Therapeutics plc | 520.52M | -1.34% | 59,821 | 839.00K |
| 465 | VSTM | Verastem, Inc. | 519.77M | 1.81% | 152,621 | 49.59M |
| 466 | RZLT | Rezolute, Inc. | 519.20M | - | 130,351 | - |
| 467 | VREX | Varex Imaging Corporation | 512.50M | -1.70% | 20,144 | 857.50M |
| 468 | AUTL | Autolus Therapeutics plc | 512.33M | -1.28% | 425,597 | 92.62M |
| 469 | ASMB | Assembly Biosciences, Inc. | 512.08M | 0.61% | 8,871 | 71.10M |
| 470 | SRTA | Strata Critical Medical, Inc. | 508.68M | 3.23% | 415,771 | 255.98M |
| 471 | PROK | ProKidney Corp. | 507.46M | 3.07% | 139,053 | 889.00K |
| 472 | BIOA | BioAge Labs, Inc. | 504.98M | 1.43% | 134,767 | 10.32M |
| 473 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 474 | FLGT | Fulgent Genetics, Inc. | 501.88M | -1.67% | 63,445 | 323.93M |
| 475 | OVID | Ovid Therapeutics Inc. | 489.00M | 3.15% | 262,705 | 7.12M |
| 476 | QTTB | Q32 Bio Inc. | 488.43M | 1.58% | 146,015 | 53.74M |
| 477 | VALN | Valneva SE | 484.44M | 2.14% | 6,849 | 180.25M |
| 478 | AQST | Aquestive Therapeutics, Inc. | 480.54M | 2.41% | 248,199 | 50.27M |
| 479 | EVMN | Evommune, Inc. | 476.16M | 0.84% | 121,358 | 10.00M |
| 480 | KYTX | Kyverna Therapeutics, Inc. | 474.81M | 0.39% | 70,740 | - |
| 481 | SLBT | SL Science Holding Limited | 473.56M | -4.87% | 51,016 | 3.27M |
| 482 | IKT | Inhibikase Therapeutics, Inc. | 469.01M | -1.64% | 231,324 | 1.00 |
| 483 | SI | Shoulder Innovations, Inc. | 467.85M | -0.57% | 6,023 | 53.89M |
| 484 | NPCE | NeuroPace, Inc. | 466.74M | -3.18% | 22,411 | 99.53M |
| 485 | CERS | Cerus Corporation | 461.49M | 4.57% | 767,175 | 221.55M |
| 486 | PRTA | Prothena Corporation plc | 457.04M | 2.83% | 75,246 | 57.94M |
| 487 | PRLD | Prelude Therapeutics Incorporated | 455.72M | 1.66% | 19,114 | 16.72M |
| 488 | PACB | Pacific Biosciences of California, Inc. | 453.48M | 1.39% | 741,808 | 160.03M |
| 489 | CABA | Cabaletta Bio, Inc. | 448.40M | -0.72% | 1,406,557 | - |
| 490 | DCTH | Delcath Systems, Inc. | 446.36M | -1.60% | 39,020 | 90.44M |
| 491 | OCGN | Ocugen, Inc. | 443.46M | - | 1,507,614 | 4.47M |
| 492 | CTEV | Claritev Corporation | 442.56M | -1.67% | 6,344 | 978.76M |
| 493 | LRMR | Larimar Therapeutics, Inc. | 439.45M | 2.43% | 401,464 | - |
| 494 | EDIT | Editas Medicine, Inc. | 435.83M | 2.53% | 257,357 | 38.69M |
| 495 | STRO | Sutro Biopharma, Inc. | 431.99M | 1.56% | 12,739 | 99.61M |
| 496 | OFIX | Orthofix Medical Inc. | 431.91M | -12.42% | 345,793 | 833.19M |
| 497 | NRC | NRC Health | 431.72M | -0.46% | 4,768 | 140.00M |
| 498 | BNTC | Benitec Biopharma Inc. | 431.49M | 0.32% | 5,573 | - |
| 499 | NNNN | Anbio Biotechnology | 431.01M | -3.25% | 389 | 8.65M |
| 500 | VTVT | vTv Therapeutics Inc. | 429.37M | 7.92% | 12,165 | 36.84M |